IP Group plc:企業のM&A・事業提携・投資動向

◆英語タイトル:IP Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1517
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:148
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:一般ビジネス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

IP Group plc – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s IP Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by IP Group plc since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes IP Group plc’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by IP Group plc. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on IP Group plc’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by IP Group plc and its subsidiaries since 2007.
- Information about key financial and legal advisors for IP Group plc’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about IP Group plc’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions – Overview 8
Mergers and Acquisitions – Deal reports 9
CORPORATE VENTURING 33
Corporate Venturing – Overview 33
Corporate Venturing – Deal reports 34
CAPITAL RAISING 124
Capital Raising – Overview 124
Capital Raising – Deal reports 125
DIVESTMENTS 128
Divestments – Overview 128
Divestments – Deal reports 129
APPENDIX 138
Contact Us 138
About MarketLine Financial Deals Database 138
Deal Definition and Methodology 140
About MarketLine 147

List of Tables
Table 1: IP Group plc M&A volume and value trend (2014-YTD2018)
Table 2: IP Group plc M&A activity by geography (2014-YTD2018)
Table 3: IP Group plc corporate venturing volume and value trend (2014-YTD2018)
Table 4: IP Group plc corporate venturing by geography (2014-YTD2018)
Table 5: IP Group plc capital raising volume and value trend (2014-YTD2018)
Table 6: IP Group plc capital raising by deal type (2014-YTD2018)
Table 7: IP Group plc divestments volume and value trend (2014-YTD2018)
Table 8: IP Group plc divestments activity by geography (2014-YTD2018)

List of Figures
Figure 1: IP Group plc M&A volume and value trend (2014-YTD2018)
Figure 2: IP Group plc M&A activity by geography (2014-YTD2018)
Figure 3: IP Group plc corporate venturing volume and value trend (2014-YTD2018)
Figure 4: IP Group plc corporate venturing by geography (2014-YTD2018)
Figure 5: IP Group plc capital raising volume and value trend (2014-YTD2018)
Figure 6: IP Group plc capital raising by deal type (2014-YTD2018)
Figure 7: IP Group plc divestments volume and value trend (2014-YTD2018)
Figure 8: IP Group plc divestments by geography (2014-YTD2018)

★海外企業調査レポート[IP Group plc:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • C. R. Bard Inc (BCR)-医療機器分野:企業M&A・提携分析
    Summary C. R. Bard Inc (Bard) is a medical device company, which offers medical, surgical, diagnostic and patient care devices related to vascular disorders, urology disorders, cancer diagnosis and treatment and surgical specialties. Its major products include devices for the treatment of peripheral …
  • WGL Holdings, Inc.:企業の戦略・SWOT・財務情報
    WGL Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary WGL Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Alberici Corp:企業の戦略的SWOT分析
    Alberici Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • F-star Biotechnology Ltd-製薬・医療分野:企業M&A・提携分析
    Summary F-star Biotechnology Ltd (F-star) is a drug development company that offers novel bispecific antibodies. The company develops immuno-oncology bispecific antibody therapeutics. Its technologies comprise modular antibody technology, a proprietary engine that generates bispecific antibodies; mA …
  • Sunstar Holding AG:戦略・SWOT・企業財務分析
    Sunstar Holding AG - Strategy, SWOT and Corporate Finance Report Summary Sunstar Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Inchcape plc (INCH):企業の財務・戦略的SWOT分析
    Inchcape plc (INCH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • National Reinsurance Corporation Of The Philippines:企業の戦略・SWOT・財務分析
    National Reinsurance Corporation Of The Philippines - Strategy, SWOT and Corporate Finance Report Summary National Reinsurance Corporation Of The Philippines - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's stru …
  • University of Oslo-製薬・医療分野:企業M&A・提携分析
    Summary University of Oslo (UiO), formerly Birkeland Innovation is an educational service provider that offers research and training services. The university offers bachelor degree program, master’s degree program, PhD program; and research-based education. It offers IT services such as username, pa …
  • Church & Dwight Co Inc:企業の戦略・SWOT・財務情報
    Church & Dwight Co Inc - Strategy, SWOT and Corporate Finance Report Summary Church & Dwight Co Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • SAE Towers Holdings LLC:企業の戦略的SWOT分析
    SAE Towers Holdings LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Woori Bank:企業のM&A・事業提携・投資動向
    Woori Bank - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Woori Bank Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Maxwell Technologies Inc. (MXWL):電力:M&Aディール及び事業提携情報
    Summary Maxwell Technologies, Inc. (Maxwell) formerly Maxwell Laboratories, Inc., is a manufacturer of capacitor-based energy storage systems and power delivery solutions. The company develops, manufactures and markets energy storage and power delivery products for transportation and other applicati …
  • Baylor Scott & White Health-製薬・医療分野:企業M&A・提携分析
    Summary Baylor Scott & White Health (Baylor Scott & White) is a non-profit organization that provides medical care services. The organization provides medical education, medical services and conducts medical research. It offers medical services in the area of emergency care, cancer care, behavioral …
  • Pantheon Resources plc Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Pantheon Resources plc Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Pantheon Resources plc Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive informat …
  • Blueprint Medicines Corp (BPMC):製薬・医療:M&Aディール及び事業提携情報
    Summary Blueprint Medicines Corp (Blueprint Medicines), formerly Hoyle Pharmaceuticals Inc, is a drug discovery company that develops drugs for the treatment of cancers and rare diseases. The company discovers and develops selective kinase inhibitors for genomically defined cancer subsets. Its pipel …
  • Active Motif Inc-製薬・医療分野:企業M&A・提携分析
    Summary Active Motif Inc (Active Motif) is a healthcare company that develops and delivers biological research tools. The company’s products comprise antibodies, extracts, fluorescent dyes, kits, reporter assays, molecules and recombinant proteins. It offers products for transcriptional regulation, …
  • ACTIVE Network, LLC:企業のM&A・事業提携・投資動向
    ACTIVE Network, LLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ACTIVE Network, LLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Capital City Bank Group Inc:企業の戦略・SWOT・財務分析
    Capital City Bank Group Inc - Strategy, SWOT and Corporate Finance Report Summary Capital City Bank Group Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Invuity Inc (IVTY):医療機器:M&Aディール及び事業提携情報
    Summary Invuity Inc (Invuity) is a medical technology company that develops and markets advanced surgical devices for the minimally invasive and minimal access procedures. The company offers illuminated surgical retractors, single-use handheld aspiration and universal drop-in intracavity illuminator …
  • Aptevo Therapeutics Inc (APVO):製薬・医療:M&Aディール及び事業提携情報
    Summary Aptevo Therapeutics Inc (Aptevo), a subsidiary of Emergent Biosolutions Inc, is a biotechnology company that develops and commercializes oncology and hematology therapeutics. The company’s only marketed product Ixinity that is indicated to replace the missing clotting factor IX in adults and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆